MANATT, PHELPS, AND PHILLIPS

Lobbying for ALEXION PHARMACEUTICALS · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $15,000.00 income · posted Oct 16, 2025

Lobbying activity 1

Health Issues

Regulation of in vitro diagnostics and lab-developed tests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem